跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mRNA: A
首页
药物
mRNA: A
mRNA: A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Optimized influenza A H3N2 mRNA vaccine
申请人: NAMEIXIN SHANGHAI BIOTECHNOLOGY CO LTD
优先权: 2023
CN
A 5'-CAP ANALOG MODIFIED mRNA
申请人: NANJING GENELEAP BIOTECHNOLOGY CO LTD
优先权: 2023
US
2 件公开
Group A streptococcus mRNA vaccine and application thereof
申请人: UNIV HARBIN MEDICAL
优先权: 2026
CN
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
申请人: VON DER MUELBE FLORIAN
优先权: 2001
EP
US
10 件公开
PLASMID CONTAINING A SEQUENCE ENCODING AN MRNA WITH A SEGMENTED POLY(A) TAIL
申请人: ETHRIS GMBH
优先权: 2018
CN
EP
2 件公开
Poly (A) sequence for optimizing mRNA preparation and expression
申请人: NAMEIXIN SHANGHAI BIOTECHNOLOGY CO LTD
优先权: 2023
CN
HA-mRNA vaccine for preventing influenza A virus infection
申请人: MILITARY MEDICINE RES INSTITUTE OF CHINESE PEOPLE LIBERATION ARMY AND MILITARY SCIENCE INSTITUTE
优先权: 2020
CN
Method of introducing an mRNA molecule into a cell
申请人: PCI BIOTECH AS
优先权: 2018
CN
US
2 件公开
药物
反馈